Immunic (IMUX) Enterprise Value (2013 - 2026)
Immunic (IMUX) reported Enterprise Value of -$186.6 million for Q1 2026, down 1204.53% on a YoY basis from $16.9 million in Q1 2025, and down 1105.19% sequentially from -$15.5 million in Q4 2025.
Immunic (IMUX) Enterprise Value (2013 - 2026) Analysis & Trends
Immunic (IMUX) has 14 years of Enterprise Value data on file, last reported at -$186.6 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 1204.53% year-over-year to -$186.6 million; the trailing twelve-month figure through Mar 2026 stood at -$186.6 million (down 1204.53% YoY), and the FY2025 full-year result was -$15.5 million, up 56.59% from the prior year.
- Enterprise Value fell to -$186.6 million in Q1 2026, from -$15.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$14.3 million in Q1 2025 to a low of -$186.6 million in Q1 2026.
- A 5-year average of -$72.5 million and a median of -$72.8 million in 2022 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value surged 85.3% in 2025 and plunged 1204.53% in 2026, its largest moves.
- Tracing IMUX's Enterprise Value over 5 years: stood at -$116.4 million in 2022, then jumped by 59.89% to -$46.7 million in 2023, then grew by 23.58% to -$35.7 million in 2024, then soared by 56.59% to -$15.5 million in 2025, then tumbled by 1105.19% to -$186.6 million in 2026.
- Business Quant data shows IMUX's Enterprise Value at -$186.6 million in Q1 2026, -$15.5 million in Q4 2025, and -$35.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Immunic | 11.03 Mn | 11.03 Mn | - | -186.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -186.60 Mn |
| Dec 31, 2025 | -15.48 Mn |
| Sep 30, 2025 | -35.13 Mn |
| Jun 30, 2025 | -55.31 Mn |
| Mar 31, 2025 | -14.30 Mn |
| Dec 31, 2024 | -35.67 Mn |
| Sep 30, 2024 | -59.07 Mn |
| Jun 30, 2024 | -79.70 Mn |
| Mar 31, 2024 | -97.31 Mn |
| Dec 31, 2023 | -46.67 Mn |
| Sep 30, 2023 | -59.70 Mn |
| Jun 30, 2023 | -77.30 Mn |
| Mar 31, 2023 | -97.11 Mn |
| Dec 31, 2022 | -116.37 Mn |
| Sep 30, 2022 | -72.77 Mn |
| Jun 30, 2022 | -88.10 Mn |
| Mar 31, 2022 | -95.70 Mn |
| Dec 31, 2021 | -86.86 Mn |
| Sep 30, 2021 | -110.44 Mn |
| Jun 30, 2021 | -87.20 Mn |